ArticleMolecular therapy oncolytics2021

Development of a seven-gene tumor immune microenvironment prognostic signature for high-risk grade III endometrial cancer.

Mingjun Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.